|
|
|
 SERVIER Canada Inc. is the Canadian subsidiary of SERVIER, the leading French independent pharmaceutical company. Present in 140 countries around the world, SERVIER distinguishes itself by investing 25 percent of its income in research and development which is approximately double the industry average. This enables the advancement of scientific knowledge, the discovery of therapeutic innovations and creating highly skilled and qualified employment opportunities throughout the world. SERVIER is maintaining its steep growth profile by bringing several innovative drugs onto the market in the next few years, addressing the following therapeutic areas: osteoporosis, cardiology and neuropsychiatry. For questions regarding your personal health, please consult a qualified healthcare professional. He/she is the best source of information regarding your health. SERVIER CANADA INC. PRODUCTS AND THEIR YEAR OF INTRODUCTION PrCOVERSYL® 2mg, 4mg - 1994 PrCOVERSYL® 8mg - 2003 PrCOVERSYL® PLUS - 2003 PrCOVERSYL® PLUS HD - 2009 PrCOVERSYL® PLUS LD (previously known under the name PrPRETERAX®) - 2003 PrDIAMICRON® 80mg - 1990 PrDIAMICRON® MR 30 mg - 2001 PrLOZIDE® 1.25mg - 1995 PrLOZIDE® 2.5mg - 1982 The information contained in this Web Site is intended for Canadian residents only. If you are not a Canadian resident, please refer to the regulatory and medical practices applicable in the country in which you reside. |
||||
© 2009 LES LABORATOIRES SERVIER, an incorporated company of SERVIER |
